Sutent, also known by its generic name sunitinib, is a prescription medication categorized as a tyrosine kinase inhibitor (TKI). It is primarily used for the treatment of certain types of cancer, including advanced renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).
As a tyrosine kinase inhibitor, Sutent works by inhibiting the actions of specific proteins called tyrosine kinases. These proteins are involved in signaling pathways that regulate cell growth and division. By blocking the activity of these proteins, Sutent helps to slow down or halt the progression of cancer cells.
The administration of Sutent is typically through oral tablets that are taken once daily. The dosage may vary depending on the individual's medical condition and response to treatment. It is crucial to follow the prescribed dosing instructions provided by a healthcare professional.
While Sutent can be effective in the treatment of certain cancers, it may also have some potential side effects. Common side effects may include fatigue, diarrhea, nausea, loss of appetite, high blood pressure, and changes in skin color. Not everyone will experience these side effects, and their severity may vary from person to person.
In summary, Sutent is a prescription medication used to treat advanced renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). As a tyrosine kinase inhibitor, it works by inhibiting specific proteins involved in tumor growth and division. It is important to take Sutent as directed by a healthcare professional and be aware of potential side effects.
